Preconditioning by angiotensin II: A tale of more than two kinases

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 2, 2006, Pages 223-225

  Dawn, Buddhadeb ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

APOPTOSIS; CELL MEMBRANE; EDITORIAL; ENZYME ACTIVATION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE FUNCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MAP KINASE SIGNALING SYSTEM; MULTIENZYME COMPLEXES; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; NADH, NADPH OXIDOREDUCTASES; OXIDATION-REDUCTION; PERFUSION; PROTEIN KINASES; RATS; REACTIVE OXYGEN SPECIES;

EID: 33746080896     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.05.005     Document Type: Editorial

References (28)

1. Cohen M.V., Baines C.P., and Downey J.M. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 62 (2000) 79-109
2. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83 (2003) 1113-1151
3. Peach M.J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57 (1977) 313-370
4. Gavras H., Lever A.F., Brown J.J., Macadam R.F., and Robertson J.I. Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet 2 (1971) 19-22
5. Pfeffer J.M., Fischer T.A., and Pfeffer M.A. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu Rev Physiol 57 (1995) 805-826
6. Bader M. Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models. J Mol Cell Cardiol 34 (2002) 1455-1462
7. Das S, Otani H, Maulik N, Das DK. Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling. J Mol Cell Cardiol 2006 (in press). doi:10.1016/j.yjmcc.2006.03.009.
8. Liu Y., Tsuchida A., Cohen M.V., and Downey J.M. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 27 (1995) 883-892
9. Diaz R.J., and Wilson G.J. Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts. J Mol Cell Cardiol 29 (1997) 129-139
10. Sharma A., and Singh M. Role of angiotensin in cardioprotective effect of ischemic preconditioning. J Cardiovasc Pharmacol 33 (1999) 772-778
11. Schwarz E.R., Montino H., Fleischhauer J., Klues H.G., vom Dahl J., and Hanrath P. Angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable with enalaprilat and augments preconditioning in the pig heart. Cardiovasc Drugs Ther 11 (1997) 687-695
12. Hunyady L., and Catt K.J. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 20 (2006) 953-970
13. Griendling K.K., and Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91 (2000) 21-27
14. Seshiah P.N., Weber D.S., Rocic P., Valppu L., Taniyama Y., and Griendling K.K. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91 (2002) 406-413
15. Wu S., Gao J., Ohlemeyer C., Roos D., Niessen H., Kottgen E., et al. Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes. Free Radic Biol Med 39 (2005) 1601-1610
16. Steenbergen C. The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning. Basic Res Cardiol 97 (2002) 276-285
17. Strohm C., Barancik T., Bruhl M.L., Kilian S.A., and Schaper W. Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium. J Cardiovasc Pharmacol 36 (2000) 218-229
18. Kim S.O., Baines C.P., Critz S.D., Pelech S.L., Katz S., Downey J.M., et al. Ischemia induced activation of heat shock protein 27 kinases and casein kinase 2 in the preconditioned rabbit heart. Biochem Cell Biol 77 (1999) 559-567
19. Mocanu M.M., Bell R.M., and Yellon D.M. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol 34 (2002) 661-668
20. Weinbrenner C., Liu G.S., Cohen M.V., and Downey J.M. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 29 (1997) 2383-2391
21. Maulik N., Yoshida T., Zu Y.L., Sato M., Banerjee A., and Das D.K. Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2. Am J Physiol 275 (1998) H1857-H1864
22. Borsch-Haubold A.G., Pasquet S., and Watson S.P. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J Biol Chem 273 (1998) 28766-28772
23. Kalmes A., Deou J., Clowes A.W., and Daum G. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580. FEBS Lett 444 (1999) 71-74
24. Clerk A., and Sugden P.H. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett 426 (1998) 93-96
25. Kimura S., Zhang G.X., Nishiyama A., Shokoji T., Yao L., Fan Y.Y., et al. Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 45 (2005) 860-866
26. Xie Z., Singh M., and Singh K. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J Cell Physiol 198 (2004) 399-407
27. Cuenda A., Cohen P., Buee-Scherrer V., and Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 16 (1997) 295-305
28. Court N.W., dos Remedios C.G., Cordell J., and Bogoyevitch M.A. Cardiac expression and subcellular localization of the p38 mitogen-activated protein kinase member, stress-activated protein kinase-3 (SAPK3). J Mol Cell Cardiol 34 (2002) 413-426